Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W2FG
|
|||
| Former ID |
DIB013385
|
|||
| Drug Name |
OPHD-001
|
|||
| Synonyms |
C difficile therapy, Ophidian/Lilly; CDAD antitoxin, Ophidian/Lilly; Clostridium difficile therapy, Ophidian/Lilly
Click to Show/Hide
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Discontinued in Phase 1 | [1] | |
| Company |
Ophidian Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011558) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.